Home › Prostate Cancer › District of Columbia
Prostate Cancer clinical trials in District of Columbia
18 studies for Prostate Cancer are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06136650Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT03866382Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RecruitingPhase 2
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT04038502A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 17, 2026 · NCT06925737Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- George Washington University Medical Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 10, 2026 · NCT05946213Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Sep 2, 2026 · NCT05334069Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 2, 2026 · NCT06931340MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
RecruitingPhase 2
Ages 18 and older · Men · Updated Aug 20, 2026 · NCT07644598Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Men · Updated Aug 19, 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT05919264Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Men · Updated Jul 14, 2026 · NCT06592924Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- VA Medical Center, Washington D.C.
RecruitingPhase 4
Ages 18 to 100 · Men · Updated Jun 4, 2026 · NCT05803941Cancer Experience Registry (CER) for Cancer Patients and Caregivers
- Cancer Support Community Research & Training Institute, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT02333604Clinical Trial of Approaches to Prostate Cancer Surgery
- Georgetown University, Washington D.C.
Recruiting
Ages 40 to 80 · Men · Updated Apr 22, 2026 · NCT05155501Castrate Resistant Prostate Cancer Enhertu Therapy
- Washington DC VAMC, Washington D.C.
RecruitingPhase 2
Ages 18 and older · Men · Updated Apr 13, 2026 · NCT06610825Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
RecruitingPhase 2/3
Ages 18 and older · Men · Updated Apr 8, 2026 · NCT04787744Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
- Howard University Hospital, Washington D.C.
RecruitingHealthy volunteers welcome
Ages 40 to 69 · Men · Updated Nov 10, 2025 · NCT06398639Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- George Washington University Medical Center, Washington D.C.
RecruitingPhase 3
Ages 18 and older · Men · Updated Sep 11, 2025 · NCT03678025From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.